APO Research
Talk to an analyst

APO RESEARCH · REPORT

FIC Single-target Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global FIC Single-target Drugs Market Analysis and Forecast 2026-2032

29 December 2025207 pages

Choose your research edition.

Industry ResearchFIC Single-target Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal FIC Single-target Drugs Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal FIC Single-target Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FIC Single-target Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal FIC Single-target Drugs Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global FIC Single-target Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for FIC Single-target Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for FIC Single-target Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for FIC Single-target Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for FIC Single-target Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of FIC Single-target Drugs include Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer, Polarean lmaging and Phathom, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for FIC Single-target Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of FIC Single-target Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for FIC Single-target Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the FIC Single-target Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global FIC Single-target Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for FIC Single-target Drugs sales, projected growth trends, production technology, application and end-user industry.

FIC Single-target Drugs Segment by Company

Sanofi

Johnson & Johnson

Novartis

Merck

Roche

Eli Lilly

Pfizer

Polarean lmaging

Phathom

Marinus

Mallinckrodt

ImmunoGen

Immunocore

Gilead

Genentech

Dermavant Sciences

Boehringer Ingelheim

BMS

Agios

FIC Single-target Drugs Segment by Type

ALK2 Inhibitors

Citron Inhibitors

GCN2 Agonists

RORγ Covalent Inhibitors

Others

FIC Single-target Drugs Segment by Application

Hospital

Clinic

Other

FIC Single-target Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FIC Single-target Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FIC Single-target Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FIC Single-target Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of FIC Single-target Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of FIC Single-target Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, FIC Single-target Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global FIC Single-target Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ALK2 Inhibitors Major Manufacturers Table 3. Citron Inhibitors Major Manufacturers Table 4. GCN2 Agonists Major Manufacturers Table 5. RORγ Covalent Inhibitors Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global FIC Single-target Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Manufacturers Table 9. Clinic Major Manufacturers Table 10. Other Major Manufacturers Table 11. FIC Single-target Drugs Industry Trends Table 12. FIC Single-target Drugs Industry Drivers Table 13. FIC Single-target Drugs Industry Opportunities and Challenges Table 14. FIC Single-target Drugs Industry Restraints Table 15. Global FIC Single-target Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global FIC Single-target Drugs Revenue by Region (2021-2026) & (US$ Million) Table 17. Global FIC Single-target Drugs Revenue by Region (2027-2032) & (US$ Million) Table 18. Global FIC Single-target Drugs Revenue Market Share by Region (2021-2026) Table 19. Global FIC Single-target Drugs Revenue Market Share by Region (2027-2032) Table 20. Global FIC Single-target Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global FIC Single-target Drugs Sales by Region (2021-2026) & (K Units) Table 22. Global FIC Single-target Drugs Sales by Region (2027-2032) & (K Units) Table 23. Global FIC Single-target Drugs Sales Market Share by Region (2021-2026) Table 24. Global FIC Single-target Drugs Sales Market Share by Region (2027-2032) Table 25. Global FIC Single-target Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global FIC Single-target Drugs Revenue Market Share by Manufacturers (2021-2026) Table 27. Global FIC Single-target Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global FIC Single-target Drugs Sales Market Share by Manufacturers (2021-2026) Table 29. Global FIC Single-target Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global FIC Single-target Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global FIC Single-target Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global FIC Single-target Drugs Manufacturers, Product Type & Application Table 33. Global FIC Single-target Drugs Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global FIC Single-target Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global FIC Single-target Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global FIC Single-target Drugs Revenue by Type (2021-2026) & (US$ Million) Table 38. Global FIC Single-target Drugs Revenue by Type (2027-2032) & (US$ Million) Table 39. Global FIC Single-target Drugs Revenue Market Share by Type (2021-2026) Table 40. Global FIC Single-target Drugs Revenue Market Share by Type (2027-2032) Table 41. Global FIC Single-target Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global FIC Single-target Drugs Sales by Type (2021-2026) & (K Units) Table 43. Global FIC Single-target Drugs Sales by Type (2027-2032) & (K Units) Table 44. Global FIC Single-target Drugs Sales Market Share by Type (2021-2026) Table 45. Global FIC Single-target Drugs Sales Market Share by Type (2027-2032) Table 46. Global FIC Single-target Drugs Price by Type (2021-2026) & (US$/Unit) Table 47. Global FIC Single-target Drugs Price by Type (2027-2032) & (US$/Unit) Table 48. Global FIC Single-target Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global FIC Single-target Drugs Revenue by Application (2021-2026) & (US$ Million) Table 50. Global FIC Single-target Drugs Revenue by Application (2027-2032) & (US$ Million) Table 51. Global FIC Single-target Drugs Revenue Market Share by Application (2021-2026) Table 52. Global FIC Single-target Drugs Revenue Market Share by Application (2027-2032) Table 53. Global FIC Single-target Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global FIC Single-target Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global FIC Single-target Drugs Sales by Application (2027-2032) & (K Units) Table 56. Global FIC Single-target Drugs Sales Market Share by Application (2021-2026) Table 57. Global FIC Single-target Drugs Sales Market Share by Application (2027-2032) Table 58. Global FIC Single-target Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global FIC Single-target Drugs Price by Application (2027-2032) & (US$/Unit) Table 60. Sanofi Company Information Table 61. Sanofi Business Overview Table 62. Sanofi FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Sanofi FIC Single-target Drugs Product Portfolio Table 64. Sanofi Recent Development Table 65. Johnson & Johnson Company Information Table 66. Johnson & Johnson Business Overview Table 67. Johnson & Johnson FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Johnson & Johnson FIC Single-target Drugs Product Portfolio Table 69. Johnson & Johnson Recent Development Table 70. Novartis Company Information Table 71. Novartis Business Overview Table 72. Novartis FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Novartis FIC Single-target Drugs Product Portfolio Table 74. Novartis Recent Development Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Merck FIC Single-target Drugs Product Portfolio Table 79. Merck Recent Development Table 80. Roche Company Information Table 81. Roche Business Overview Table 82. Roche FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Roche FIC Single-target Drugs Product Portfolio Table 84. Roche Recent Development Table 85. Eli Lilly Company Information Table 86. Eli Lilly Business Overview Table 87. Eli Lilly FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Eli Lilly FIC Single-target Drugs Product Portfolio Table 89. Eli Lilly Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Pfizer FIC Single-target Drugs Product Portfolio Table 94. Pfizer Recent Development Table 95. Polarean lmaging Company Information Table 96. Polarean lmaging Business Overview Table 97. Polarean lmaging FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Polarean lmaging FIC Single-target Drugs Product Portfolio Table 99. Polarean lmaging Recent Development Table 100. Phathom Company Information Table 101. Phathom Business Overview Table 102. Phathom FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Phathom FIC Single-target Drugs Product Portfolio Table 104. Phathom Recent Development Table 105. Marinus Company Information Table 106. Marinus Business Overview Table 107. Marinus FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Marinus FIC Single-target Drugs Product Portfolio Table 109. Marinus Recent Development Table 110. Mallinckrodt Company Information Table 111. Mallinckrodt Business Overview Table 112. Mallinckrodt FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Mallinckrodt FIC Single-target Drugs Product Portfolio Table 114. Mallinckrodt Recent Development Table 115. ImmunoGen Company Information Table 116. ImmunoGen Business Overview Table 117. ImmunoGen FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. ImmunoGen FIC Single-target Drugs Product Portfolio Table 119. ImmunoGen Recent Development Table 120. Immunocore Company Information Table 121. Immunocore Business Overview Table 122. Immunocore FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Immunocore FIC Single-target Drugs Product Portfolio Table 124. Immunocore Recent Development Table 125. Gilead Company Information Table 126. Gilead Business Overview Table 127. Gilead FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Gilead FIC Single-target Drugs Product Portfolio Table 129. Gilead Recent Development Table 130. Genentech Company Information Table 131. Genentech Business Overview Table 132. Genentech FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Genentech FIC Single-target Drugs Product Portfolio Table 134. Genentech Recent Development Table 135. Dermavant Sciences Company Information Table 136. Dermavant Sciences Business Overview Table 137. Dermavant Sciences FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Dermavant Sciences FIC Single-target Drugs Product Portfolio Table 139. Dermavant Sciences Recent Development Table 140. Boehringer Ingelheim Company Information Table 141. Boehringer Ingelheim Business Overview Table 142. Boehringer Ingelheim FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Boehringer Ingelheim FIC Single-target Drugs Product Portfolio Table 144. Boehringer Ingelheim Recent Development Table 145. BMS Company Information Table 146. BMS Business Overview Table 147. BMS FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. BMS FIC Single-target Drugs Product Portfolio Table 149. BMS Recent Development Table 150. Agios Company Information Table 151. Agios Business Overview Table 152. Agios FIC Single-target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Agios FIC Single-target Drugs Product Portfolio Table 154. Agios Recent Development Table 155. North America FIC Single-target Drugs Revenue by Type (2021-2026) & (US$ Million) Table 156. North America FIC Single-target Drugs Revenue by Type (2027-2032) & (US$ Million) Table 157. North America FIC Single-target Drugs Sales by Type (2021-2026) & (K Units) Table 158. North America FIC Single-target Drugs Sales by Type (2027-2032) & (K Units) Table 159. North America FIC Single-target Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 160. North America FIC Single-target Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 161. North America FIC Single-target Drugs Revenue by Application (2021-2026) & (US$ Million) Table 162. North America FIC Single-target Drugs Revenue by Application (2027-2032) & (US$ Million) Table 163. North America FIC Single-target Drugs Sales by Application (2021-2026) & (K Units) Table 164. North America FIC Single-target Drugs Sales by Application (2027-2032) & (K Units) Table 165. North America FIC Single-target Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 166. North America FIC Single-target Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 167. North America FIC Single-target Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. North America FIC Single-target Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. North America FIC Single-target Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. North America FIC Single-target Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 171. North America FIC Single-target Drugs Sales by Country (2021-2026) & (K Units) Table 172. North America FIC Single-target Drugs Sales by Country (2027-2032) & (K Units) Table 173. North America FIC Single-target Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 174. North America FIC Single-target Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 175. United States FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 176. Canada FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 177. Mexico FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 178. Europe FIC Single-target Drugs Revenue by Type (2021-2026) & (US$ Million) Table 179. Europe FIC Single-target Drugs Revenue by Type (2027-2032) & (US$ Million) Table 180. Europe FIC Single-target Drugs Sales by Type (2021-2026) & (K Units) Table 181. Europe FIC Single-target Drugs Sales by Type (2027-2032) & (K Units) Table 182. Europe FIC Single-target Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 183. Europe FIC Single-target Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 184. Europe FIC Single-target Drugs Revenue by Application (2021-2026) & (US$ Million) Table 185. Europe FIC Single-target Drugs Revenue by Application (2027-2032) & (US$ Million) Table 186. Europe FIC Single-target Drugs Sales by Application (2021-2026) & (K Units) Table 187. Europe FIC Single-target Drugs Sales by Application (2027-2032) & (K Units) Table 188. Europe FIC Single-target Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 189. Europe FIC Single-target Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 190. Europe FIC Single-target Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Europe FIC Single-target Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Europe FIC Single-target Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Europe FIC Single-target Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 194. Europe FIC Single-target Drugs Sales by Country (2021-2026) & (K Units) Table 195. Europe FIC Single-target Drugs Sales by Country (2027-2032) & (K Units) Table 196. Europe FIC Single-target Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 197. Europe FIC Single-target Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 198. Germany FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 199. France FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 200. U.K. FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 201. Italy FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 202. Russia FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 203. Spain FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 204. Netherlands FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 205. Switzerland FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 206. Sweden FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 207. Poland FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 208. China FIC Single-target Drugs Revenue by Type (2021-2026) & (US$ Million) Table 209. China FIC Single-target Drugs Revenue by Type (2027-2032) & (US$ Million) Table 210. China FIC Single-target Drugs Sales by Type (2021-2026) & (K Units) Table 211. China FIC Single-target Drugs Sales by Type (2027-2032) & (K Units) Table 212. China FIC Single-target Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 213. China FIC Single-target Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 214. China FIC Single-target Drugs Revenue by Application (2021-2026) & (US$ Million) Table 215. China FIC Single-target Drugs Revenue by Application (2027-2032) & (US$ Million) Table 216. China FIC Single-target Drugs Sales by Application (2021-2026) & (K Units) Table 217. China FIC Single-target Drugs Sales by Application (2027-2032) & (K Units) Table 218. China FIC Single-target Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 219. China FIC Single-target Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 220. Asia FIC Single-target Drugs Revenue by Type (2021-2026) & (US$ Million) Table 221. Asia FIC Single-target Drugs Revenue by Type (2027-2032) & (US$ Million) Table 222. Asia FIC Single-target Drugs Sales by Type (2021-2026) & (K Units) Table 223. Asia FIC Single-target Drugs Sales by Type (2027-2032) & (K Units) Table 224. Asia FIC Single-target Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 225. Asia FIC Single-target Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 226. Asia FIC Single-target Drugs Revenue by Application (2021-2026) & (US$ Million) Table 227. Asia FIC Single-target Drugs Revenue by Application (2027-2032) & (US$ Million) Table 228. Asia FIC Single-target Drugs Sales by Application (2021-2026) & (K Units) Table 229. Asia FIC Single-target Drugs Sales by Application (2027-2032) & (K Units) Table 230. Asia FIC Single-target Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 231. Asia FIC Single-target Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 232. Asia FIC Single-target Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 233. Asia FIC Single-target Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 234. Asia FIC Single-target Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 235. Asia FIC Single-target Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 236. Asia FIC Single-target Drugs Sales by Country (2021-2026) & (K Units) Table 237. Asia FIC Single-target Drugs Sales by Country (2027-2032) & (K Units) Table 238. Asia FIC Single-target Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 239. Asia FIC Single-target Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 240. Japan FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 241. South Korea FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 242. India FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 243. Australia FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 244. Taiwan FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 245. Southeast Asia FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 246. SAMEA FIC Single-target Drugs Revenue by Type (2021-2026) & (US$ Million) Table 247. SAMEA FIC Single-target Drugs Revenue by Type (2027-2032) & (US$ Million) Table 248. SAMEA FIC Single-target Drugs Sales by Type (2021-2026) & (K Units) Table 249. SAMEA FIC Single-target Drugs Sales by Type (2027-2032) & (K Units) Table 250. SAMEA FIC Single-target Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 251. SAMEA FIC Single-target Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 252. SAMEA FIC Single-target Drugs Revenue by Application (2021-2026) & (US$ Million) Table 253. SAMEA FIC Single-target Drugs Revenue by Application (2027-2032) & (US$ Million) Table 254. SAMEA FIC Single-target Drugs Sales by Application (2021-2026) & (K Units) Table 255. SAMEA FIC Single-target Drugs Sales by Application (2027-2032) & (K Units) Table 256. SAMEA FIC Single-target Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 257. SAMEA FIC Single-target Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 258. SAMEA FIC Single-target Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 259. SAMEA FIC Single-target Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 260. SAMEA FIC Single-target Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 261. SAMEA FIC Single-target Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 262. SAMEA FIC Single-target Drugs Sales by Country (2021-2026) & (K Units) Table 263. SAMEA FIC Single-target Drugs Sales by Country (2027-2032) & (K Units) Table 264. SAMEA FIC Single-target Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 265. SAMEA FIC Single-target Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 266. Brazil FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 267. Argentina FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 268. Chile FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 269. Colombia FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 270. Peru FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 271. Saudi Arabia FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 272. Israel FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 273. UAE FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 274. Turkey FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 275. Iran FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 276. Egypt FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Table 277. Key Raw Materials Table 278. Raw Materials Key Suppliers Table 279. FIC Single-target Drugs Distributors List Table 280. FIC Single-target Drugs Customers List Table 281. Research Programs/Design for This Report Table 282. Authors List of This Report Table 283. Secondary Sources Table 284. Primary Sources List of Figures Figure 1. FIC Single-target Drugs Image Figure 2. Global FIC Single-target Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FIC Single-target Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. ALK2 Inhibitors Image Figure 5. Citron Inhibitors Image Figure 6. GCN2 Agonists Image Figure 7. RORγ Covalent Inhibitors Image Figure 8. Others Image Figure 9. Global FIC Single-target Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global FIC Single-target Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Other Image Figure 14. Global FIC Single-target Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global FIC Single-target Drugs Revenue (2021-2032) & (US$ Million) Figure 16. Global FIC Single-target Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global FIC Single-target Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global FIC Single-target Drugs Revenue Market Share by Region (2021-2032) Figure 19. Global FIC Single-target Drugs Sales (2021-2032) & (K Units) Figure 20. Global FIC Single-target Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global FIC Single-target Drugs Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico FIC Single-target Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Europe FIC Single-target Drugs Sales YoY (2021-2032) & (K Units) Figure 24. China FIC Single-target Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) FIC Single-target Drugs Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa FIC Single-target Drugs Sales YoY (2021-2032) & (K Units) Figure 27. Global FIC Single-target Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global FIC Single-target Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global FIC Single-target Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global FIC Single-target Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global FIC Single-target Drugs Revenue Market Share by Type (2021-2032) Figure 33. Global FIC Single-target Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global FIC Single-target Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global FIC Single-target Drugs Sales Market Share by Type (2021-2032) Figure 36. Global FIC Single-target Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global FIC Single-target Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global FIC Single-target Drugs Revenue Market Share by Application (2021-2032) Figure 39. Global FIC Single-target Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global FIC Single-target Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global FIC Single-target Drugs Sales Market Share by Application (2021-2032) Figure 42. North America FIC Single-target Drugs Revenue Share by Type (2021-2032) Figure 43. North America FIC Single-target Drugs Sales Share by Type (2021-2032) Figure 44. North America FIC Single-target Drugs Revenue Share by Application (2021-2032) Figure 45. North America FIC Single-target Drugs Sales Share by Application (2021-2032) Figure 46. North America FIC Single-target Drugs Revenue Share by Country (2021-2032) Figure 47. North America FIC Single-target Drugs Sales Share by Country (2021-2032) Figure 48. Europe FIC Single-target Drugs Revenue Share by Type (2021-2032) Figure 49. Europe FIC Single-target Drugs Sales Share by Type (2021-2032) Figure 50. Europe FIC Single-target Drugs Revenue Share by Application (2021-2032) Figure 51. Europe FIC Single-target Drugs Sales Share by Application (2021-2032) Figure 52. Europe FIC Single-target Drugs Revenue Share by Country (2021-2032) Figure 53. Europe FIC Single-target Drugs Sales Share by Country (2021-2032) Figure 54. China FIC Single-target Drugs Revenue Share by Type (2021-2032) Figure 55. China FIC Single-target Drugs Sales Share by Type (2021-2032) Figure 56. China FIC Single-target Drugs Revenue Share by Application (2021-2032) Figure 57. China FIC Single-target Drugs Sales Share by Application (2021-2032) Figure 58. Asia FIC Single-target Drugs Revenue Share by Type (2021-2032) Figure 59. Asia FIC Single-target Drugs Sales Share by Type (2021-2032) Figure 60. Asia FIC Single-target Drugs Revenue Share by Application (2021-2032) Figure 61. Asia FIC Single-target Drugs Sales Share by Application (2021-2032) Figure 62. Asia FIC Single-target Drugs Revenue Share by Country (2021-2032) Figure 63. Asia FIC Single-target Drugs Sales Share by Country (2021-2032) Figure 64. SAMEA FIC Single-target Drugs Revenue Share by Type (2021-2032) Figure 65. SAMEA FIC Single-target Drugs Sales Share by Type (2021-2032) Figure 66. SAMEA FIC Single-target Drugs Revenue Share by Application (2021-2032) Figure 67. SAMEA FIC Single-target Drugs Sales Share by Application (2021-2032) Figure 68. SAMEA FIC Single-target Drugs Revenue Share by Country (2021-2032) Figure 69. SAMEA FIC Single-target Drugs Sales Share by Country (2021-2032) Figure 70. FIC Single-target Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. FIC Single-target Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • ALK2 Inhibitors
  • Citron Inhibitors
  • GCN2 Agonists
  • RORγ Covalent Inhibitors
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • Polarean lmaging
  • Phathom
  • Marinus
  • Mallinckrodt
  • ImmunoGen
  • Immunocore
  • Gilead
  • Genentech
  • Dermavant Sciences
  • Boehringer Ingelheim
  • BMS
  • Agios

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 FIC Single-target Drugs Market by Type
  3. 1.2.1 Global FIC Single-target Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ALK2 Inhibitors
  5. 1.2.3 Citron Inhibitors
  6. 1.2.4 GCN2 Agonists
  7. 1.2.5 RORγ Covalent Inhibitors
  8. 1.2.6 Others
  9. 1.3 FIC Single-target Drugs Market by Application
  10. 1.3.1 Global FIC Single-target Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 FIC Single-target Drugs Market Dynamics
  1. 2.1 FIC Single-target Drugs Industry Trends
  2. 2.2 FIC Single-target Drugs Industry Drivers
  3. 2.3 FIC Single-target Drugs Industry Opportunities and Challenges
  4. 2.4 FIC Single-target Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global FIC Single-target Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global FIC Single-target Drugs Revenue by Region
  3. 3.2.1 Global FIC Single-target Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global FIC Single-target Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global FIC Single-target Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global FIC Single-target Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global FIC Single-target Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global FIC Single-target Drugs Sales by Region
  9. 3.4.1 Global FIC Single-target Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global FIC Single-target Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global FIC Single-target Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global FIC Single-target Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global FIC Single-target Drugs Revenue by Manufacturers
  2. 4.1.1 Global FIC Single-target Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global FIC Single-target Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global FIC Single-target Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global FIC Single-target Drugs Sales by Manufacturers
  6. 4.2.1 Global FIC Single-target Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global FIC Single-target Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global FIC Single-target Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global FIC Single-target Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global FIC Single-target Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global FIC Single-target Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global FIC Single-target Drugs Manufacturers, Product Type & Application
  13. 4.7 Global FIC Single-target Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global FIC Single-target Drugs Market CR5 and HHI
  16. 4.8.2 2025 FIC Single-target Drugs Tier 1, Tier 2, and Tier 3
5 FIC Single-target Drugs Market by Type
  1. 5.1 Global FIC Single-target Drugs Revenue by Type
  2. 5.1.1 Global FIC Single-target Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global FIC Single-target Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global FIC Single-target Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global FIC Single-target Drugs Sales by Type
  6. 5.2.1 Global FIC Single-target Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global FIC Single-target Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global FIC Single-target Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global FIC Single-target Drugs Price by Type
6 FIC Single-target Drugs Market by Application
  1. 6.1 Global FIC Single-target Drugs Revenue by Application
  2. 6.1.1 Global FIC Single-target Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global FIC Single-target Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global FIC Single-target Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global FIC Single-target Drugs Sales by Application
  6. 6.2.1 Global FIC Single-target Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global FIC Single-target Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global FIC Single-target Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global FIC Single-target Drugs Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi FIC Single-target Drugs Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson FIC Single-target Drugs Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis FIC Single-target Drugs Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck FIC Single-target Drugs Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Roche FIC Single-target Drugs Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 Eli Lilly
  32. 7.6.1 Eli Lilly Company Information
  33. 7.6.2 Eli Lilly Business Overview
  34. 7.6.3 Eli Lilly FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eli Lilly FIC Single-target Drugs Product Portfolio
  36. 7.6.5 Eli Lilly Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer FIC Single-target Drugs Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Polarean lmaging
  44. 7.8.1 Polarean lmaging Company Information
  45. 7.8.2 Polarean lmaging Business Overview
  46. 7.8.3 Polarean lmaging FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Polarean lmaging FIC Single-target Drugs Product Portfolio
  48. 7.8.5 Polarean lmaging Recent Developments
  49. 7.9 Phathom
  50. 7.9.1 Phathom Company Information
  51. 7.9.2 Phathom Business Overview
  52. 7.9.3 Phathom FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Phathom FIC Single-target Drugs Product Portfolio
  54. 7.9.5 Phathom Recent Developments
  55. 7.10 Marinus
  56. 7.10.1 Marinus Company Information
  57. 7.10.2 Marinus Business Overview
  58. 7.10.3 Marinus FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Marinus FIC Single-target Drugs Product Portfolio
  60. 7.10.5 Marinus Recent Developments
  61. 7.11 Mallinckrodt
  62. 7.11.1 Mallinckrodt Company Information
  63. 7.11.2 Mallinckrodt Business Overview
  64. 7.11.3 Mallinckrodt FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Mallinckrodt FIC Single-target Drugs Product Portfolio
  66. 7.11.5 Mallinckrodt Recent Developments
  67. 7.12 ImmunoGen
  68. 7.12.1 ImmunoGen Company Information
  69. 7.12.2 ImmunoGen Business Overview
  70. 7.12.3 ImmunoGen FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 ImmunoGen FIC Single-target Drugs Product Portfolio
  72. 7.12.5 ImmunoGen Recent Developments
  73. 7.13 Immunocore
  74. 7.13.1 Immunocore Company Information
  75. 7.13.2 Immunocore Business Overview
  76. 7.13.3 Immunocore FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Immunocore FIC Single-target Drugs Product Portfolio
  78. 7.13.5 Immunocore Recent Developments
  79. 7.14 Gilead
  80. 7.14.1 Gilead Company Information
  81. 7.14.2 Gilead Business Overview
  82. 7.14.3 Gilead FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Gilead FIC Single-target Drugs Product Portfolio
  84. 7.14.5 Gilead Recent Developments
  85. 7.15 Genentech
  86. 7.15.1 Genentech Company Information
  87. 7.15.2 Genentech Business Overview
  88. 7.15.3 Genentech FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Genentech FIC Single-target Drugs Product Portfolio
  90. 7.15.5 Genentech Recent Developments
  91. 7.16 Dermavant Sciences
  92. 7.16.1 Dermavant Sciences Company Information
  93. 7.16.2 Dermavant Sciences Business Overview
  94. 7.16.3 Dermavant Sciences FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Dermavant Sciences FIC Single-target Drugs Product Portfolio
  96. 7.16.5 Dermavant Sciences Recent Developments
  97. 7.17 Boehringer Ingelheim
  98. 7.17.1 Boehringer Ingelheim Company Information
  99. 7.17.2 Boehringer Ingelheim Business Overview
  100. 7.17.3 Boehringer Ingelheim FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Boehringer Ingelheim FIC Single-target Drugs Product Portfolio
  102. 7.17.5 Boehringer Ingelheim Recent Developments
  103. 7.18 BMS
  104. 7.18.1 BMS Company Information
  105. 7.18.2 BMS Business Overview
  106. 7.18.3 BMS FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 BMS FIC Single-target Drugs Product Portfolio
  108. 7.18.5 BMS Recent Developments
  109. 7.19 Agios
  110. 7.19.1 Agios Company Information
  111. 7.19.2 Agios Business Overview
  112. 7.19.3 Agios FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Agios FIC Single-target Drugs Product Portfolio
  114. 7.19.5 Agios Recent Developments
8 North America
  1. 8.1 North America FIC Single-target Drugs Market Size by Type
  2. 8.1.1 North America FIC Single-target Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America FIC Single-target Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America FIC Single-target Drugs Price by Type (2021-2032)
  5. 8.2 North America FIC Single-target Drugs Market Size by Application
  6. 8.2.1 North America FIC Single-target Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America FIC Single-target Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America FIC Single-target Drugs Price by Application (2021-2032)
  9. 8.3 North America FIC Single-target Drugs Market Size by Country
  10. 8.3.1 North America FIC Single-target Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America FIC Single-target Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America FIC Single-target Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe FIC Single-target Drugs Market Size by Type
  2. 9.1.1 Europe FIC Single-target Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe FIC Single-target Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe FIC Single-target Drugs Price by Type (2021-2032)
  5. 9.2 Europe FIC Single-target Drugs Market Size by Application
  6. 9.2.1 Europe FIC Single-target Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe FIC Single-target Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe FIC Single-target Drugs Price by Application (2021-2032)
  9. 9.3 Europe FIC Single-target Drugs Market Size by Country
  10. 9.3.1 Europe FIC Single-target Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe FIC Single-target Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe FIC Single-target Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China FIC Single-target Drugs Market Size by Type
  2. 10.1.1 China FIC Single-target Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China FIC Single-target Drugs Sales by Type (2021-2032)
  4. 10.1.3 China FIC Single-target Drugs Price by Type (2021-2032)
  5. 10.2 China FIC Single-target Drugs Market Size by Application
  6. 10.2.1 China FIC Single-target Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China FIC Single-target Drugs Sales by Application (2021-2032)
  8. 10.2.3 China FIC Single-target Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia FIC Single-target Drugs Market Size by Type
  2. 11.1.1 Asia FIC Single-target Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia FIC Single-target Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia FIC Single-target Drugs Price by Type (2021-2032)
  5. 11.2 Asia FIC Single-target Drugs Market Size by Application
  6. 11.2.1 Asia FIC Single-target Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia FIC Single-target Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia FIC Single-target Drugs Price by Application (2021-2032)
  9. 11.3 Asia FIC Single-target Drugs Market Size by Country
  10. 11.3.1 Asia FIC Single-target Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia FIC Single-target Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia FIC Single-target Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA FIC Single-target Drugs Market Size by Type
  2. 12.1.1 SAMEA FIC Single-target Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA FIC Single-target Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA FIC Single-target Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA FIC Single-target Drugs Market Size by Application
  6. 12.2.1 SAMEA FIC Single-target Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA FIC Single-target Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA FIC Single-target Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA FIC Single-target Drugs Market Size by Country
  10. 12.3.1 SAMEA FIC Single-target Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA FIC Single-target Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA FIC Single-target Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 FIC Single-target Drugs Value Chain Analysis
  2. 13.1.1 FIC Single-target Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 FIC Single-target Drugs Production Mode & Process
  6. 13.2 FIC Single-target Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 FIC Single-target Drugs Distributors
  9. 13.2.3 FIC Single-target Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst